0001140361-18-032817.txt : 20180718
0001140361-18-032817.hdr.sgml : 20180718
20180718182200
ACCESSION NUMBER: 0001140361-18-032817
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180716
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lalonde James
CENTRAL INDEX KEY: 0001599677
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34705
FILM NUMBER: 18959205
MAIL ADDRESS:
STREET 1: C/O CODEXIS, INC.
STREET 2: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CODEXIS INC
CENTRAL INDEX KEY: 0001200375
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 710872999
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-421-8100
MAIL ADDRESS:
STREET 1: 200 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2018-07-16
0
0001200375
CODEXIS INC
CDXS
0001599677
Lalonde James
C/O CODEXIS, INC.
200 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
SVP, R&D
Common Stock
2018-07-16
4
S
0
7500
15.5276
D
202566
D
Common Stock
2018-07-17
4
S
0
7500
15.2737
D
195066
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 8, 2017.
This transaction was executed in multiple trades in prices ranging from $15.35 to $15.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $14.90 to $15.425, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
/s/ Gordon Sangster, Attorney-in-Fact for James Lalonde
2018-07-18